Impact BioMedical Inc’s recently made public that its 10% Owner DSS, INC. unloaded Company’s shares for reported $1.65 million on Mar 21 ’25. In the deal valued at $3.30 per share,499,800 shares were sold. As a result of this transaction, DSS, INC. now holds 0 shares worth roughly $0.0.
Then, DSS, INC. sold 58,139 shares, generating $182,134 in total proceeds. Upon selling the shares at $3.13, the 10% Owner now owns 1,099,481 shares.
Before that, DSS, INC. sold 47,681 shares. Impact BioMedical Inc shares valued at $119,255 were divested by the 10% Owner at a price of $2.50 per share. As a result of the transaction, DSS, INC. now holds 1,051,800 shares, worth roughly $0.92 million.
Price Performance Review of IBO
On Monday, Impact BioMedical Inc [AMEX:IBO] saw its stock fall -42.76% to $0.87. Over the last five days, the stock has lost -75.83%. Impact BioMedical Inc shares have fallen nearly -40.00% since the year began. SMA at 50 days reached $24.84, while 200 days put it at $24.11.
Levels Of Support And Resistance For IBO Stock
The 24-hour chart illustrates a support level at 24.84, which if violated will result in even more drops to 24.84. On the upside, there is a resistance level at 24.84. A further resistance level may holdings at 24.84. The Relative Strength Index (RSI) on the 14-day chart is 43.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.00%. Stochastics %K at 50.00% indicates the stock is a holding.
How much short interest is there in Impact BioMedical Inc?
A steep rise in short interest was recorded in Impact BioMedical Inc stocks on 2025-03-14, dropping by 3104.0 shares to a total of 9001.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 12105.0 shares. There was a decline of -34.49%, which implies that there is a negative sentiment for the stock.
